v3.26.1
Consolidated Statements of Changes in Stockholders' (Deficit) Equity - USD ($)
shares in Thousands, $ in Thousands
Common stock
Additional paid-in-capital
Accumulated deficit
Total
Beginning Balance at Dec. 31, 2023 $ 30 $ 534,060 $ (590,598) $ (56,508)
Beginning Balance (in shares) at Dec. 31, 2023 1,871      
Issuance of common stock, net of offering costs $ 19 9,907   9,926
Issuance of common stock, net of offering costs (in shares) 1,209      
Stock-based compensation   6,156   6,156
Repricing of stock purchase warrants   59   59
Issuance of stock purchase warrants   2,540   2,540
Issuance of pre-funded stock purchase warrants   4,379   4,379
Vesting of restricted stock units, net of employee tax obligations   (54)   (54)
Vesting of restricted stock units, net of employee tax obligations (in shares) 22      
Net Income (Loss)     (59,599) (59,599)
Ending Balance at Dec. 31, 2024 $ 49 557,047 (650,197) $ (93,101)
Ending Balance (in shares) at Dec. 31, 2024 3,102     3,102
Issuance of common stock, net of offering costs $ 27 55,333   $ 55,360
Issuance of common stock, net of offering costs (in shares) 19,153      
Stock-based compensation   2,669   2,669
Issuance of stock purchase warrants       0
Issuance of pre-funded stock purchase warrants   9,523   9,523
Vesting of restricted stock units, net of employee tax obligations   (17)   (17)
Vesting of restricted stock units, net of employee tax obligations (in shares) 73      
Net Income (Loss)     (69,897) (69,897)
Ending Balance at Dec. 31, 2025 $ 76 $ 624,555 $ (720,094) $ (95,463)
Ending Balance (in shares) at Dec. 31, 2025 22,328     22,328